{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:48:39Z","timestamp":1789652919318,"version":"4.0.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107608","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:26:02Z","timestamp":1618367162000},"page":"107608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Inflammatory mediators in various molecular pathways involved in the development of pulmonary fibrosis"],"prefix":"10.1016","volume":"96","author":[{"given":"M.","family":"Fathimath Muneesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya B.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Jeena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-3561","authenticated-orcid":false,"given":"Yashodhar P.","family":"Bhandary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.4808","article-title":"The extracellular matrix - the under-recognized element in lung disease?","volume":"240","author":"Burgess","year":"2016","journal-title":"J. Pathol. [Internet]."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med. [Internet]."},{"issue":"14","key":"10.1016\/j.intimp.2021.107608_b0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2466-14-139","article-title":"Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature","volume":"16","author":"Kistler","year":"2014","journal-title":"BMC Pulm. Med. [Internet]."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1753465810379801","article-title":"The pathogenesis of idiopathic pulmonary fibrosis","volume":"4","author":"Coward","year":"2010","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.iac.2012.08.006","article-title":"Idiopathic pulmonary fibrosis","volume":"32","author":"Zolak","year":"2012","journal-title":"Immunol. Allergy Clin. North Am."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0030","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","article-title":"Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis","volume":"166","author":"Willis","year":"2005","journal-title":"Am. J. Pathol. [Internet]."},{"issue":"21","key":"10.1016\/j.intimp.2021.107608_b0035","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/00029330-200711010-00015","article-title":"Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis","volume":"120","author":"Li","year":"2007","journal-title":"Chin Med. J. (Engl)."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0040","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ajpath.2011.07.042","article-title":"Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis","volume":"179","author":"Rieder","year":"2011","journal-title":"Am. J. Pathol. [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0045","doi-asserted-by":"crossref","unstructured":"Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, et al. Alveolar epithelial cell mesenchymal transition develops &lt;em&gt;in vivo&lt;\/em&gt; during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci [Internet]. 2006 Aug 29;103(35):13180 LP \u2013 13185. Available from: http:\/\/www.pnas.org\/content\/103\/35\/13180.abstract.","DOI":"10.1073\/pnas.0605669103"},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-6-56","article-title":"TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)","volume":"6","author":"Kasai","year":"2005","journal-title":"Respir. Res. [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0055","doi-asserted-by":"crossref","unstructured":"Shaikh SB, Prabhu A, Bhandary YP. Curcumin targets p53-fibrinolytic system in TGF-\u03b21 mediated alveolar epithelial mesenchymal transition in alveolar epithelial cells. Endocr Metab Immune Disord Drug Targets. 2020 Sep.","DOI":"10.2174\/1871530320666200929142503"},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/pats.201203-025AW","article-title":"Idiopathic pulmonary fibrosis: An altered fibroblast proliferation linked to cancer biology","volume":"9","author":"Vancheri","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/ijms20061461","article-title":"Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review","volume":"20","author":"Kinoshita","year":"2019","journal-title":"Int. J. Mol. Sci. [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0070","doi-asserted-by":"crossref","unstructured":"Wang A, Wang F, Yin Y, Zhang M, Chen P. Dexamethasone reduces serum level of IL-17 in Bleomycin-A5-induced rats model of pulmonary fibrosis. Artif Cells, Nanomedicine, Biotechnol [Internet]. 2018 May 19;46(4):783\u20137. Available from: https:\/\/doi.org\/10.1080\/21691401.2017.1339051.","DOI":"10.1080\/21691401.2017.1339051"},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0075","first-page":"366","article-title":"IL-17A promotes pulmonary inflammation in rats with pulmonary fibrosis induced by bleomycin","volume":"30","author":"Huang","year":"2014","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0080","doi-asserted-by":"crossref","unstructured":"Wang T, Liu Y, Zou J-F, Cheng Z-S. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-\u03b21 mediated Smad2\/3 and ERK1\/2 activation. PLoS One [Internet]. 2017 Sep 5;12(9):e0183972\u2013e0183972. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28873461.","DOI":"10.1371\/journal.pone.0183972"},{"issue":"7","key":"10.1016\/j.intimp.2021.107608_b0085","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1007\/s11033-020-05587-0","article-title":"Curcumin attenuates IL-17A mediated pulmonary SMAD dependent and non-dependent mechanism during acute lung injury in vivo","volume":"47","author":"Shaikh","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0090","first-page":"12","article-title":"IL-17A and GDF15 are able to induce epithelial-mesenchymal transition of lung epithelial cells in response to cigarette smoke","volume":"16","author":"Jiang","year":"2018","journal-title":"Exp. Ther. Med. [Internet]."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0095","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.18632\/oncotarget.6570","article-title":"IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.intimp.2021.107608_b0100","first-page":"1482","article-title":"IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling","volume":"11","author":"Shintani","year":"2016","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2018.11.129","article-title":"Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition","volume":"508","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun. [Internet]."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coi.2007.09.002","article-title":"The inflammasome: a danger sensing complex triggering innate immunity","volume":"19","author":"Petrilli","year":"2007","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2021.107608_b0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2017.01.014","article-title":"Inflammasomes in the lung","volume":"86","author":"Pinkerton","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.107608_b0125","doi-asserted-by":"crossref","unstructured":"Li X, Yan X, Wang Y, Wang J, Zhou F, Wang H, et al. NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells. Exp Cell Res [Internet]. 2018;362(2):489\u201397. Available from: https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.013.","DOI":"10.1016\/j.yexcr.2017.12.013"},{"issue":"44","key":"10.1016\/j.intimp.2021.107608_b0130","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1038\/onc.2009.247","article-title":"Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3","volume":"28","author":"Kaler","year":"2009","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0135","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1159\/000430185","article-title":"Interleukin-1\u03b2 Promotes Epithelial-Derived Alveolar Elastogenesis via \u03b1v\u03b26 Integrin-Dependent TGF-\u03b2 Activation","volume":"36","author":"Wang","year":"2015","journal-title":"Cell Physiol. Biochem. [Internet]"},{"key":"10.1016\/j.intimp.2021.107608_b0140","doi-asserted-by":"crossref","unstructured":"Cho SJ, Moon J-S, Nikahira K, Yun HS, Harris R, Hong KS, et al. GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation. Thorax [Internet]. 2020 Mar 1;75(3):227 LP \u2013 236. Available from: http:\/\/thorax.bmj.com\/content\/75\/3\/227.abstract.","DOI":"10.1136\/thoraxjnl-2019-213571"},{"key":"10.1016\/j.intimp.2021.107608_b0145","first-page":"1","article-title":"Activation of the absent in melanoma 2 inflammasome in peripheral blood mononuclear cells from Idiopathic pulmonary fibrosis patients leads to the release of pro-fibrotic mediators","author":"Terlizzi","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051668","article-title":"DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis","volume":"21","author":"Cho","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2021.107608_b0155","doi-asserted-by":"crossref","unstructured":"O\u2019Beirne SL, Walsh SM, Fabre A, Reviriego C, Worrell JC, Counihan IP, et al. CXCL9 Regulates TGF-\u03b21-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells. J Immunol [Internet]. 2015\/08\/12. 2015 Sep 15;195(6):2788\u201396. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26268659.","DOI":"10.4049\/jimmunol.1402008"},{"key":"10.1016\/j.intimp.2021.107608_b0160","article-title":"Interleukin-22 Inhibits Bleomycin-Induced Pulmonary","author":"Liang","year":"2013","journal-title":"Fibrosis"},{"key":"10.1016\/j.intimp.2021.107608_b0165","doi-asserted-by":"crossref","unstructured":"Chen Q, Luo AA, Qiu H, Han B, Ko BH-K, Slutsky AS, et al. Monocyte interaction accelerates HCl-induced lung epithelial remodeling. BMC Pulm Med [Internet]. 2014;14(1):135. Available from: https:\/\/doi.org\/10.1186\/1471-2466-14-135.","DOI":"10.1186\/1471-2466-14-135"},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0170","doi-asserted-by":"crossref","first-page":"L1129","DOI":"10.1152\/ajplung.2000.279.6.L1129","article-title":"Autocrine regulation of interleukin-8 production in human monocytes","volume":"279","author":"Browning","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","article-title":"Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-\/- mice","volume":"40","author":"Bruscia","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2021.107608_b0180","doi-asserted-by":"crossref","unstructured":"Park sung woo, Kim CR, Lee EH, Kim JH, Park JS, Lee JH, et al. Intranasal administration of IL-37 attenuates bleomycin induced experimental lung injury\/fibrosis. FASEB J [Internet]. 2013 Apr 1;27(1_supplement):1166.12-1166.12. Available from: https:\/\/www.fasebj.org\/doi\/abs\/10.1096\/fasebj.27.1_supplement.1166.12.","DOI":"10.1096\/fasebj.27.1_supplement.1166.12"},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0185","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s10753-018-0820-9","article-title":"Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice","volume":"41","author":"Li","year":"2018","journal-title":"Inflammation"},{"issue":"8","key":"10.1016\/j.intimp.2021.107608_b0190","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.1801515","article-title":"IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-beta1 Production in Mice","volume":"203","author":"Kim","year":"2019","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0195","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3892\/or.2016.4995","article-title":"CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2021.107608_b0200","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.107608_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12860-016-0084-x","article-title":"IL-27 inhibits the TGF-\u03b21-induced epithelial-mesenchymal transition in alveolar epithelial cells","volume":"17","author":"Dong","year":"2016","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.intimp.2021.107608_b0210","doi-asserted-by":"crossref","unstructured":"Drakopanagiotakis F, Xifteri A, Polychronopoulos V, Bouros D. Apoptosis in lung injury and fibrosis. Eur Respir J [Internet]. 2008 Dec 1;32(6):1631 LP \u2013 1638. Available from: http:\/\/erj.ersjournals.com\/content\/32\/6\/1631.abstract.","DOI":"10.1183\/09031936.00176807"},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0215","article-title":"Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis","volume":"37","author":"Kasper","year":"2017","journal-title":"Biosci. Rep. [Internet]."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.127.1.266","article-title":"Expression of Apoptotic and Antiapoptotic Markers in Epithelial Cells in Idiopathic Pulmonary Fibrosis","volume":"127","author":"Plataki","year":"2005","journal-title":"Chest [Internet]."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-0773.2003.920204.x","article-title":"Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists","volume":"92","author":"Uhal","year":"2003","journal-title":"Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jcp.54.2.132","article-title":"Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)\/usual interstitial pneumonia (UIP)","volume":"54","author":"Barbas-Filho","year":"2001","journal-title":"J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1165\/rcmb.2011-0025RT","article-title":"Prostaglandin E2 and the pathogenesis of pulmonary fibrosis","volume":"45","author":"Bozyk","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"109","key":"10.1016\/j.intimp.2021.107608_b0240","article-title":"The role of apoptosis in pulmonary fibrosis","volume":"17","author":"Uhal","year":"2008","journal-title":"Eur. Respir. Rev. [Internet]."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0245","doi-asserted-by":"crossref","first-page":"L501","DOI":"10.1152\/ajplung.00273.2002","article-title":"Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo","volume":"284","author":"Li","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-4652(200011)185:2<253::AID-JCP10>3.0.CO;2-#","article-title":"Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo","volume":"185","author":"Wang","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2021.107608_b0255","doi-asserted-by":"crossref","unstructured":"Murray ME, Gavile CM, Nair JR, Koorella C, Carlson LM, Buac D, et al. CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood [Internet]. 2014\/04\/29. 2014 Jun 12;123(24):3770\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24782505.","DOI":"10.1182\/blood-2013-10-530964"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107608_b0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imlet.2013.12.020","article-title":"CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes","volume":"158","author":"Camperio","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2021.107608_b0265","doi-asserted-by":"crossref","unstructured":"Kunkl M, Mastrogiovanni M, Porciello N, Caristi S, Monteleone E, Arcieri S, et al. CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA\/NF-\u03baB and STAT3 Transcription Factors on the Proximal Promoter. Front Immunol [Internet]. 2019 Apr 24;10:864. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31068940.","DOI":"10.3389\/fimmu.2019.00864"},{"issue":"9","key":"10.1016\/j.intimp.2021.107608_b0270","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1002\/jcb.27026","article-title":"Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo","volume":"119","author":"Gouda","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0275","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jcb.26384","article-title":"Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells","volume":"119","author":"Gouda","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10565-016-9322-4","article-title":"Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia","volume":"32","author":"Chen","year":"2016","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2021.107608_b0285","first-page":"1","article-title":"Regulatory mechanism of NOV\/CCN3 in the inflammation and apoptosis of lung epithelial alveolar cells upon lipopolysaccharide stimulation","author":"Zhu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.107608_b0290","doi-asserted-by":"crossref","unstructured":"Schuliga M. The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease. 2015;2015.","DOI":"10.1155\/2015\/437695"},{"key":"10.1016\/j.intimp.2021.107608_b0295","doi-asserted-by":"crossref","unstructured":"McKeown S, Richter AG, O&#039;Kane C, McAuley DF, Thickett DR. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J [Internet]. 2009 Jan 1;33(1):77 LP \u2013 84. Available from: http:\/\/erj.ersjournals.com\/content\/33\/1\/77.abstract.","DOI":"10.1183\/09031936.00060708"},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/thoraxjnl-2013-203740","article-title":"Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study","volume":"69","author":"Navaratnam","year":"2014","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.intimp.2021.107608_b0305","first-page":"567","article-title":"PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax","volume":"55","author":"Zentina","year":"2019","journal-title":"Medicina (Kaunas) [Internet]."},{"issue":"33","key":"10.1016\/j.intimp.2021.107608_b0310","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1073\/pnas.0801394105","article-title":"PAI-1 inhibits neutrophil efferocytosis","volume":"105","author":"Park","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0315","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.20.6.1682","article-title":"Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes","volume":"20","author":"Birgel","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107608_b0320","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/INF.0b013e318170b678","article-title":"Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions","volume":"27","author":"Chiu","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0325","first-page":"1","article-title":"The role of cytokines in fibrinolysis: A case study of active tuberculosis","volume":"1","author":"Akpan","year":"2017","journal-title":"J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.intimp.2021.107608_b0330","doi-asserted-by":"crossref","unstructured":"Shetty P, Velusamy T, Bhandary YP, Shetty RS, Liu M-C, Shetty S. Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover. Am J Respir Cell Mol Biol [Internet]. 2008\/04\/03. 2008 Sep;39(3):364\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18390474.","DOI":"10.1165\/rcmb.2007-0406OC"},{"key":"10.1016\/j.intimp.2021.107608_b0335","doi-asserted-by":"crossref","unstructured":"Shetty S, Velusamy T, Idell S, Shetty P, Mazar AP, Bhandary YP, et al. Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA. Mol Cell Biol [Internet]. 2007\/06\/04. 2007 Aug;27(16):5607\u201318. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17548471.","DOI":"10.1128\/MCB.00080-07"},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0340","doi-asserted-by":"crossref","first-page":"L496","DOI":"10.1152\/ajplung.00290.2015","article-title":"p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure","volume":"310","author":"Tiwari","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0345","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.20.6.1682","article-title":"Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes","volume":"20","author":"Birgel","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2021.107608_b0350","doi-asserted-by":"crossref","unstructured":"Garrett SM, Hsu E, Thomas JM, Pilewski JM, Feghali-Bostwick C. Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions. PLoS One [Internet]. 2019;14(11):1\u201321. Available from: http:\/\/dx.doi.org\/10.1371\/journal.pone.0225422.","DOI":"10.1371\/journal.pone.0225422"},{"key":"10.1016\/j.intimp.2021.107608_b0355","article-title":"Fibrinogen Is a Specific Trigger for","author":"Coden","year":"2019","journal-title":"Cytolytic. Eosinophil. Degranulat."},{"key":"10.1016\/j.intimp.2021.107608_b0360","doi-asserted-by":"crossref","unstructured":"Rubel C, Fern\u00e1ndez GC, Rosa FA, G\u00f3mez S, Bompadre MB, Coso OA, et al. Soluble Fibrinogen Modulates Neutrophil Functionality Through the Activation of an Extracellular Signal-Regulated Kinase-Dependent Pathway. J Immunol [Internet]. 2002 Apr 1;168(7):3527 LP \u2013 3535. Available from: http:\/\/www.jimmunol.org\/content\/168\/7\/3527.abstract.","DOI":"10.4049\/jimmunol.168.7.3527"},{"issue":"11","key":"10.1016\/j.intimp.2021.107608_b0365","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0370","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s10753-018-0742-6","article-title":"IL-33 Can Promote the Process of Pulmonary Fibrosis by Inducing the Imbalance Between MMP-9 and TIMP-1","volume":"41","author":"Wu","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2021.107608_b0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2014.01.008","article-title":"The LRP1-independent mechanism of PAI-1-induced migration in CpG-ODN activated macrophages","volume":"49","author":"Thapa","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"26","key":"10.1016\/j.intimp.2021.107608_b0380","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1182\/blood-2011-12-399659","article-title":"Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice","volume":"119","author":"Tashiro","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107608_b0385","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107608_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.05.006","article-title":"ERK5 regulates basic fibroblast growth factor-induced type 1 plasminogen activator inhibitor expression and cell proliferation in lung fibroblasts","volume":"135","author":"Han","year":"2015","journal-title":"Life Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0395","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-5-11","article-title":"Molecular and cellular mechanisms of pulmonary fibrosis","volume":"5","author":"Todd","year":"2012","journal-title":"Fibrogenesis Tissue Repair."},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jcp.2005.026872","article-title":"Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia","volume":"59","author":"Choi","year":"2006","journal-title":"J. Clin. Pathol. [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0410","doi-asserted-by":"crossref","unstructured":"Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Evanoff H, Flaherty KR, et al. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J [Internet]. 2007 Jun 1;29(6):1082 LP \u2013 1093. Available from: http:\/\/erj.ersjournals.com\/content\/29\/6\/1082.abstract.","DOI":"10.1183\/09031936.00122806"},{"key":"10.1016\/j.intimp.2021.107608_b0415","doi-asserted-by":"crossref","unstructured":"Ma Z, Yu R, Zhu Q, Sun L, Jian L, Wang X, et al. CXCL16\/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K\/AKT\/FOXO3a pathway. Int Immunopharmacol [Internet]. 2020;81:106035. Available from: http:\/\/europepmc.org\/abstract\/MED\/31753588.","DOI":"10.1016\/j.intimp.2019.106035"},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0420","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","article-title":"Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs","volume":"29","author":"Moodley","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0425","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9440(10)63658-9","article-title":"Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6\/gp130-mediated cell signaling and proliferation","volume":"163","author":"Moodley","year":"2003","journal-title":"Am. J. Pathol. [Internet]"},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0704769","article-title":"Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts","volume":"136","author":"Scaffidi","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0435","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajpath.2011.12.022","article-title":"STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP\/IPF","volume":"180","author":"Pechkovsky","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0440","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2004-0175OC","article-title":"Inhibition of pulmonary fibrosis by the chemokine IP-10\/CXCL10","volume":"31","author":"Tager","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.200609-1279OC","article-title":"Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis","volume":"176","author":"Baran","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.107608_b0450","doi-asserted-by":"crossref","unstructured":"Kass DJ, Yu G, Loh KS, Savir A, Borczuk A, Kahloon R, et al. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am J Pathol [Internet]. 2012\/03\/16. 2012 May;180(5):1963\u201378. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22429962.","DOI":"10.1016\/j.ajpath.2012.01.010"},{"key":"10.1016\/j.intimp.2021.107608_b0455","article-title":"Effect of curcumin on IL-17A mediated pulmonary AMPK kinase\/cyclooxygenase-2 expressions via activation of NF\u03baB in bleomycin-induced acute lung injury in vivo","volume":"85","author":"Shaikh","year":"2020","journal-title":"Int. Immunopharmacol. [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0460","doi-asserted-by":"crossref","unstructured":"Moradi S, Ziaei R, Foshati S, Mohammadi H, Nachvak SM, Rouhani MH. Jo ur na l P re ro of. Complement Ther Med [Internet]. 2019;102211. Available from: https:\/\/doi.org\/10.1016\/j.ctim.2019.102211.","DOI":"10.1016\/j.ctim.2019.102211"},{"key":"10.1016\/j.intimp.2021.107608_b0465","doi-asserted-by":"crossref","unstructured":"Song J, Wu C, Zhang X, Sorokin LM. In Vivo Processing of CXCL5 (LIX) by Matrix Metalloproteinase (MMP)-2 and MMP-9 Promotes Early Neutrophil Recruitment in IL-1\u03b2\u2013Induced Peritonitis. J Immunol [Internet]. 2013 Jan 1;190(1):401 LP \u2013 410. Available from: http:\/\/www.jimmunol.org\/content\/190\/1\/401.abstract.","DOI":"10.4049\/jimmunol.1202286"},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/toxsci\/kfv161","article-title":"Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-\u03b1 Antibody","volume":"148","author":"Malaviya","year":"2015","journal-title":"Toxicol. Sci. [Internet]."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2021.107608_b0475","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2011.12.025","article-title":"Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis","volume":"678","author":"Navarro-Partida","year":"2012","journal-title":"Eur. J. Pharmacol. [Internet]."},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0485","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/TP.0b013e3182584879","article-title":"Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection","volume":"94","author":"Bizargity","year":"2012","journal-title":"Transplantation [Internet]"},{"issue":"3","key":"10.1016\/j.intimp.2021.107608_b0490","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/TP.0b013e3181ae3392","article-title":"Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses","volume":"88","author":"Visner","year":"2009","journal-title":"Transplantation [Internet]."},{"key":"10.1016\/j.intimp.2021.107608_b0495","doi-asserted-by":"crossref","unstructured":"Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis. J Pharmacol Exp Ther [Internet]. 2014 May 1;349(2):209 LP \u2013 220. Available from: http:\/\/jpet.aspetjournals.org\/content\/349\/2\/209.abstract.","DOI":"10.1124\/jpet.113.208223"},{"issue":"6","key":"10.1016\/j.intimp.2021.107608_b0500","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-157-6-201209180-00003","article-title":"Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial","volume":"157","author":"Horton","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0505","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/art.30255","article-title":"Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease","volume":"63","author":"Bogatkevich","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0510","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports","volume":"134","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0515","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","article-title":"Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation","volume":"185","author":"Xu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0520","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/thoraxjnl-2012-201823","article-title":"Statins and the risk of interstitial lung disease: a cohort study","volume":"68","author":"Saad","year":"2013","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.intimp.2021.107608_b0525","doi-asserted-by":"crossref","first-page":"e0140571","DOI":"10.1371\/journal.pone.0140571","article-title":"Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease","volume":"10","author":"Vedel-Krogh","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2021.107608_b0530","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/thoraxjnl-2016-208819","article-title":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis","volume":"72","author":"Kreuter","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2021.107608_b0535","doi-asserted-by":"crossref","unstructured":"Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane database Syst Rev. 2016;4(4):CD001505.","DOI":"10.1002\/14651858.CD001505.pub4"},{"issue":"4","key":"10.1016\/j.intimp.2021.107608_b0540","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9343(00)00711-7","article-title":"Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival","volume":"110","author":"Flaherty","year":"2001","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_b0545","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1440-1843.2005.00757.x","article-title":"Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis","volume":"10","author":"Mura","year":"2005","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.intimp.2021.107608_b0550","first-page":"1421","article-title":"Semiquantitative 67Ga scintigraphy as an indicator of response to and prognosis after corticosteroid treatment in idiopathic interstitial pneumonia","volume":"46","author":"Grijm","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.107608_b0555","doi-asserted-by":"crossref","first-page":"e0116775","DOI":"10.1371\/journal.pone.0116775","article-title":"Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Schupp","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2021.107608_b0560","doi-asserted-by":"crossref","unstructured":"Balestro E, Calabrese F, Turato G, Lunardi F, Bazzan E, Marulli G, et al. Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis. PLoS One [Internet]. 2016 May 9;11(5):e0154516. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0154516.","DOI":"10.1371\/journal.pone.0154516"},{"issue":"5","key":"10.1016\/j.intimp.2021.107608_bib561","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00408-020-00386-7","article-title":"Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis","volume":"198","author":"Zinellu","year":"2020","journal-title":"Lung"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T18:54:10Z","timestamp":1727290450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":113,"alternative-id":["S1567576921002447"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107608","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory mediators in various molecular pathways involved in the development of pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107608"}}